CLOV Clover Health
- 0.631
- +0.009+1.51%
- 0.638
- +0.007+1.09%
Clover Health News
Clover Health Investments: Hold Rating With High Risk Amidst Progress Towards Stability
Analysts' Opinions Are Mixed on These Healthcare Stocks: Clover Health Investments (CLOV) and Biomea Fusion (BMEA)
Hold Rating on Clover Health Investments: Performance Upsides, Growth Concerns, and Capital Risk Factors
Hold Rating on Clover Health: Mixed Financial Performance and Future Uncertainty
Citigroup Maintains Neutral on Clover Health Investments, Raises Price Target to $1.5
Clover Health Investments Analyst Ratings
Clover Health Investments (CLOV) Receives a Sell From Bank of America Securities
SVB Securities Remains a Hold on Clover Health Investments (CLOV)
Clover Health Investments (CLOV) Gets a Sell From Bank of America Securities
Clover Health Investments (CLOV) Gets a Sell From Bank of America Securities
Credit Suisse Maintains Underperform on Clover Health Investments, Lowers Price Target to $1.25
Clover Health Investments (CLOV) Receives a Hold From SVB Securities
Credit Suisse Trims Clover Health Investments' Price Target to $2.50 From $3, Lowers 2022 to 2024 Revenue Estimatesl; Keeps Underperform Rating
SVB Securities Adjusts Price Target on Clover Health Investments to $1.50 From $3, Maintains Market Perform Rating
SVB Leerink Maintains Market Perform on Clover Health Investments, Lowers Price Target to $1.5
SVB Securities Sticks to Their Hold Rating for Clover Health Investments (CLOV)
Clover Health Investments Price Target Cut to $3.00/Share From $3.50 by Credit Suisse
BofA Securities Adjusts Clover Health Investments Price Target to $2 From $2.50, Maintains Underperform Rating
Analysis
Price Target
No Data
